Get started
Author

Wanting Qiang

A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
2022 · Xiaozhu Tang, Zhendong Deng, et al. · Journal of Experimental & Clinical Cancer Research · 53
PDF
Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma
2022 · Haiyan He, Zifeng Li, et al. · Clinical and Translational Medicine · 38
PDF
CAR‐T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status
2022 · Juan Du, Runhong Wei, et al. · American Journal of Hematology · 32
B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple Myeloma
2024 · Wanting Qiang, Jing Lu, et al. · JAMA Oncology · 31
PDF
Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma
2023 · Juan Du, Wanting Qiang, et al. · Blood · 23
Phase I Open-Label Single-Arm Study of BCMA/CD19 Dual-Targeting FasTCAR-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma
2022 · Juan Du, Weijun Fu, et al. · Blood · 18
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
2025 · Lina Jin, Sinan Gu, et al. · The Lancet Haematology · 11
A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
2024 · Dongjian Chen, Yu Zhu, et al. · Clinical Cancer Research · 11
PDF
Leukemic IL‐17RB signaling regulates leukemic survival and chemoresistance
2019 · He‐Zhou Guo, Li‐Ting Niu, et al. · The FASEB Journal · 11
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma
2024 · Pei Guo, Yun Wang, et al. · Clinical & Experimental Immunology · 9
PDF
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
2023 · Wanting Qiang, Lina Jin, et al. · Blood Cancer Journal · 8
PDF
Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36–inflammatory monocyte axis
2021 · He-Zhou Guo, Zi-Hua Guo, et al. · Science Advances · 8
Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients
2025 · Xi Chen, Tianchen Luo, et al. · BMC Medical Genomics · 7
The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma
2023 · Haiyan He, Jing Lu, et al. · Journal of Clinical Medicine · 7
PDF
Simultaneous quantification of thalidomide, lenalidomide and pomadomide in plasma by LC-MS/MS
2023 · Bin Wang, Wanting Qiang, et al. · Journal of Pharmacological and Toxicological Methods · 7
Sensitive quantitative IgD assay increases progression-free survival prediction accuracy in IgD plasma cell myeloma
2022 · Jin Liu, Jing Lu, et al. · Leukemia · 7
A dual targeting BCMA and CD19 fastcar-t (GC012F/AZD0120) as first-line therapy for newly diagnosed multiple myeloma
2025 · Juan Du, Wanting Qiang, et al. · Blood · 6
PDF
An open‐label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome
2024 · Haiyan He, Nan Hou, et al. · British Journal of Haematology · 6
PDF
Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway
2022 · Lu Li, Jin Liu, et al. · Oncology Reports · 6
PDF
GPRC5D-Targeted CAR T-Cell Therapy CT071 for the Treatment of Refractory/Relapsed Multiple Myeloma
2024 · Juan Du, Lina Jin, et al. · Blood · 5
PDF
Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients
2024 · Juan Du, Wanting Qiang, et al. · Blood · 3
PDF
Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
2021 · Tiancheng Luo, Wanting Qiang, et al. · Blood Science · 3
[Clinical characteristics and prognosis of Waldenström's macroglobulinemia: a clinical data report from a single center].
2020 · Y C Jia, J Lu, et al. · PubMed Central · 3
PDF
BCMA/CD19 dual-targeting CAR T-cell therapy in older patients with newly diagnosed multiple myeloma: a phase 1 study
2026 · Jin Liu, Xiaoqiang Fan, et al. · Blood Advances · 2
A first-in-human study of CT0596, an allogeneic CAR T-cell therapy targeting BCMA, in patients with relapsed/refractory multiple myeloma
2025 · Juan Du, Lina Jin, et al. · Blood · 2
Works count: 49
Citation count: 321
H-index: 9
I10-index: 9
Year
Topic
Type